Expression profiling of selected genes of toxication and detoxication pathways in peripheral blood lymphocytes as a biomarker for predicting toxicity of environmental chemicals

International Journal of Hygiene and Environmental Health

Volumn 216, Issue 6, 2013, Pages 645-651

  Sharma, Amit ^a,b   Saurabh, Kumar ^a   Yadav, Sanjay ^a   Jain, Swatantra K ^b   Parmar, Devendra ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b HAMDARD UNIVERSITY   (India)

Author keywords

Blood lymphocytes; Cytochrome P450; Inducers; MRNA expression; Real time PCR; TLDA

Indexed keywords

RATTUS;

3 METHYLCHOLANTHRENE; ALCOHOL; BIOLOGICAL MARKER; CYTOCHROME P450; PHENOBARBITAL; RNA; TRANSCRIPTION FACTOR; TRANSCRIPTOME;

ANIMAL; APOPTOSIS; ARTICLE; BLOOD LYMPHOCYTES; DRUG DETOXIFICATION; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; ENZYMOLOGY; GENETICS; INDUCERS; INFLAMMATION; LIVER; LYMPHOCYTE; MALE; METABOLISM; MRNA EXPRESSION; PATHOLOGY; POLLUTANT; RAT; REAL TIME POLYMERASE CHAIN REACTION; TLDA; WISTAR RAT;

BLOOD LYMPHOCYTES; CYTOCHROME P450; INDUCERS; MRNA EXPRESSION; REAL TIME PCR; TLDA;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CYTOCHROME P-450 ENZYME SYSTEM; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; ETHANOL; INFLAMMATION; LIVER; LYMPHOCYTES; MALE; METABOLIC DETOXICATION, PHASE I; METABOLIC DETOXICATION, PHASE II; METHYLCHOLANTHRENE; PHENOBARBITAL; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; RNA; TRANSCRIPTION FACTORS; TRANSCRIPTOME;

EID: 84884592072     PISSN: 14384639     EISSN: 1618131X     Source Type: Journal    
DOI: 10.1016/j.ijheh.2012.11.002     Document Type: Article

References (45)

1. Achiron A., Feldman A., Mandel M., Gurevich M. Impaired expression of peripheral blood apoptotic-related gene transcripts in acute multiple sclerosis relapse. Ann. N.Y. Acad. Sci. 2007, 1107:155-167.
2. Adachi M., Higuchi H., Miura S., Azuma T., Inokuchi S., Saito H., Kato S., Ishii H. Bax interacts with the voltage-dependent anion channel and mediates ethanol-induced apoptosis in rat hepatocytes. Am. J. Physiol. 2004, 287:G695-G705.
3. Bozina N., Bradamante V., Lovria M. Genetic polymorphism of metabolic enzymes P450 (CYP) as a susceptibility factor for drug response, toxicity, and cancer risk. Arch. Ind. Hyg. Toxicol. 2009, 60:217-242.
4. Cao J., Patisaul H.B., Petersen S.L. Aryl hydrocarbon receptor activation in lactotropes and gonadotropes interferes with estradiol-dependent and -independent preprolactin, glycoprotein alpha and luteinizing hormone beta gene expression. Mol. Cell. Endocrinol. 2011, 333:151-159.
5. Crettol S., Petrovic N., Murray M. Pharmacogenetics of phase I and phase II drug metabolism. Curr. Pharm. Des. 2010, 16:204-219.
6. de Longueville F., Surry D., Meneses-Lorente G., Bertholet V., Talbot V., Evrard S., Chandelier N., Pike A., Worboys P., Rasson J.P., Le Bourdelles B., Remacle J. Gene expression profiling of drug metabolism and toxicology markers using a low-density DNA microarray. Biochem. Pharmacol. 2002, 64:137-149.
7. Dey A., Dhawan A., Kishore Seth P., Parmar D. Evidence for cytochrome P450 2E1 catalytic activity and expression in rat blood lymphocytes. Life Sci. 2005, 77:1082-1093.
8. Dey A., Parmar D., Dayal M., Dhawan A., Seth P.K. Cytochrome P450 1A1 (CYP1A1) in blood lymphocytes evidence for catalytic activity and mRNA expression. Life Sci. 2001, 69:383-393.
9. Dey A., Parmar D., Dhawan A., Dash D., Seth P.K. Cytochrome P450 2E1 dependent catalytic activity and lipid peroxidation in rat blood lymphocytes. Life Sci. 2002, 71:2509-2519.
10. Dey A., Yadav S., Dhawan A., Seth P.K., Parmar D. Evidence for cytochrome P450 3A expression and catalytic activity in rat blood lymphocytes. Life Sci. 2006, 79:1729-1735.
11. Enoch S.J., Cronin M.T.D. A review of the electrophilic reaction chemistry involved in covalent DNA binding. Crit. Rev. Toxicol. 2010, 40:728-748.
12. Furukawa M., Nishimura M., Ogino D., Chiba R., Ikai I., Ueda N., Naito S., Kuribayashi S., Moustafa M.A., Uchida T., Sawada H., Kamataki T., Funae Y., Fukumoto M. Cytochrome p450 gene expression levels in peripheral blood mononuclear cells in comparison with the liver. Cancer Sci. 2004, 95:520-529.
13. Gerhold D., Lu M., Xu J., Austin C., Caskey C.T., Rushmore T. Monitoring expression of genes involved in drug metabolism and toxicology using DNA microarrays. Physiol. Genomics 2001, 5:161-170.
14. Gladkevich A., Nelemans S.A., Kauffman H.F., Korf J. Microarray profiling of lymphocytes in internal diseases with an altered immune response: potential and methodology. Mediators Inflamm. 2005, 2005:317-330.
15. Haupt S., Berger M., Goldberg Z., Haupt Y. Apoptosis - the p53 network. J. Cell Sci. 2003, 116:4077-4085.
16. Jaiswal A.K. Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic. Biol. Med. 2004, 36:1199-1207.
17. Khan A.J., Sharma A., Choudhuri G., Parmar D. Induction of blood lymphocyte cytochrome P450 2E1 in early stage alcoholic liver cirrhosis. Alcohol (Fayetteville, NY) 2011, 45:81-87.
18. Kondraganti S.R., Muthiah K., Jiang W., Barrios R., Moorthy B. Effects of 3-methylcholanthrene on gene expression profiling in the rat using cDNA microarray analyses. Chem. Res. Toxicol. 2005, 18:1634-1641.
19. Krovat B.C., Tracy J.H., Omiecinski C.J. Fingerprinting of cytochrome P450 and microsomal epoxide hydrolase gene expression in human blood cells. Toxicol. Sci. 2000, 55:352-360.
20. Langouet S., Morel F., Meyer D.J., Fardel O., Corcos L., Ketterer B., Guillouzo A. A comparison of the effect of inducers on the expression of glutathione-S-transferases in the liver of the intact rat and in hepatocytes in primary culture. Hepatology (Baltimore, MD) 1996, 23:881-887.
21. Li J., Bardag-Gorce F., Oliva J., French B.A., Dedes J., French S.W. The effects of betaine treatment on rats fed an acute bolus of ethanol at 3 and 12h post bolus: a microarray analysis. Genes Nutr. 2010, 5:321-329.
22. Li N., Hu Q., Jiang C., Hu Y., Yuan Y., Jian X., Tang Z., Guo F. Novel genetic biomarkers for susceptibility to oral submucous fibrosis: cytochrome P450 3A. Med. Hypotheses 2011, 77(5):834-836.
23. Li, T., Sonoda, J., Evans, R.M., 2008. Establishing orphan nuclear receptors PXR and CAR as xenobiotic receptors. Nuclear Receptors in Drug Metabolism, John Wiley & Sons, Inc., Hoboken, NJ, USA. pp. 43-59. doi:10.1002/9780470409107.ch2.
24. Ma Q., Kinneer K., Bi Y., Chan J.Y., Kan Y.W. Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap 'n' collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduction. Biochem. J. 2004, 377:205-213.
25. McHale C.M., Zhang L., Hubbard A.E., Smith M.T. Toxicogenomic profiling of chemically exposed humans in risk assessment. Mutat. Res. 2010, 705:172-183.
26. Motohashi H., Yamamoto M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol. Med. 2004, 10:549-557.
27. Muñoz B., Albores A. The role of molecular biology in the biomonitoring of human exposure to chemicals. Int. J. Mol. Sci. 2010, 11:4511-4525.
28. Nguyen L.T., Ramanathan M., Weinstock-Guttman B., Dole K., Miller C., Planter M., Patrick K., Brownscheidle C., Jacobs L.D. Detection of cytochrome P450 and other drug-metabolizing enzyme mRNAs in peripheral blood mononuclear cells using DNA arrays. Drug Metab. Dispos. 2000, 28:987-993.
29. Pavek P., Dvorak Z. Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues. Curr. Drug Metab. 2008, 9:129-143.
30. Raucy J.L., Schultz E.D., Wester M.R., Arora S., Johnston D.E., Omdahl J.L., Carpenter S.P. Human lymphocyte cytochrome P450 2E1, a putative marker for alcohol-mediated changes in hepatic chlorzoxazone activity. Drug Metab. Dispos. 1997, 25:1429-1435.
31. Satoh J., Nakanishi M., Koike F., Miyake S., Yamamoto T., Kawai M., Kikuchi S., Nomura K., Yokoyama K., Ota K., Kanda T., Fukazawa T., Yamamura T. Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis. Neurobiol. Dis. 2005, 18:537-550.
32. Saurabh K., Parmar D. Evidence for cytochrome P450 2B1/2B2 isoenzymes in freshly prepared peripheral blood lymphocytes. Biomarkers 2011, 1-8.
33. Saurabh K., Sharma A., Yadav S., Parmar D. Polycyclic aromatic hydrocarbon metabolizing cytochrome P450s in freshly prepared uncultured rat blood lymphocytes. Biochem. Pharmacol. 2010, 79:1182-1188.
34. Shah P.P., Saurabh K., Pant M.C., Mathur N., Parmar D. Evidence for increased cytochrome P450 1A1 expression in blood lymphocytes of lung cancer patients. Mutat. Res. Fundam. Mol. Mech. Mutagen. 2009, 670:74-78.
35. Sharma A., Saurabh K., Yadav S., Jain S.K., Parmar D. Ethanol induced induction of cytochrome P450 2E1 and activation of mitogen activated protein kinases in peripheral blood lymphocytes. Xenobiotica 2012, 4:317-326.
36. Shen G., Kong A.N. Nrf2 plays an important role in coordinated regulation of Phase II drug metabolism enzymes and Phase III drug transporters. Biopharm. Drug Dispos. 2009, 30:345-355.
37. Siest G., Jeannesson E., Marteau J.B., Samara A., Marie B., Pfister M., Visvikis-Siest S. Transcription factor and drug-metabolizing enzyme gene expression in lymphocytes from healthy human subjects. Drug Metab. Dispos. 2008, 36:182-189.
38. Srivastava A., Yadav S., Sharma A., Dwivedi U.N., Flora S.J.S., Parmar D. Similarities in diesel exhaust particles induced alterations in expression of cytochrome P-450 and glutathione S-transferases in rat lymphocytes and lungs. Xenobiotica 2012, 42:624-632.
39. Testa B., Kramer S.D. The biochemistry of drug metabolism-an introduction. Chem. Biodivers. 2006, 3:1053-1101.
40. Thum T., Erpenbeck V.J., Moeller J., Hohlfeld J.M., Krug N., Borlak J. Expression of xenobiotic metabolizing enzymes in different lung compartments of smokers and nonsmokers. Environ. Health Perspect. 2006, 114:1655.
41. Totlandsdal A.I., Cassee F.R., Schwarze P., Refsnes M., Låg M. Diesel exhaust particles induce CYP1A1 and pro-inflammatory responses via differential pathways in human bronchial epithelial cells. Part Fibre Toxicol. 2010, 7:41.
42. Ueda A., Hamadeh H.K., Webb H.K., Yamamoto Y., Sueyoshi T., Afshari C.A., Lehmann J.M., Negishi M. Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital. Mol. Pharmacol. 2002, 61:1-6.
43. Uppstad H., Øvrebø S., Haugen A., Mollerup S. Importance of CYP1A1 and CYP1B1 in bioactivation of benzo [a] pyrene in human lung cell lines. Toxicol. Lett. 2010, 192:221-228.
44. Yang G., Jiang Y., Rao K., Chen X., Wang Q., Wang J., Liu A., Xiong W., Yuan J. Mitochondrial dysfunction and transactivation of p53-dependent apoptotic genes in bap-treated human fetal lung fibroblasts. Hum. Exp. Toxicol. 2011, 30:1904-1913.
45. Yeligar S.M., Machida K., Kalra V.K. Ethanol-induced HO-1 and NQO1 are differentially regulated by HIF-1alpha and Nrf2 to attenuate inflammatory cytokine expression. J. Biol. Chem. 2010, 285:35359-35373.